2 completed, 1 terminated. 2 Phase 4, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Canyon Pharmaceuticals, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis Desirudin - Thrombosis | Phase 4 | Completed | Canyon Pharmaceuticals, Inc. | 516 | 2010-03-01 | 2013-01-10 |
| A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome Desirudin or Argatroban® - Suspected Heparin-Induced Thrombocytopenia | Phase 4 | Terminated | Canyon Pharmaceuticals, Inc. | 16 | 2008-09-01 | 2013-01-10 |
| Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery Desirudin (Iprivask™), Heparin - Deep Venous Thrombosis | Phase 2 / Phase 3 | Completed | Washington University School of Medicine | 120 | 2006-05-01 | 2019-03-05 |
Thrombosis (1) · Venous Thrombosis (1)
desirudin (3) · Heparin (1) · argatroban (1)
United States (3)
Dawn Bell, PharmD (2) · Bryan Meyers, MD (1) · Charles Hantler, MD (1) · Jerrold Levy, MD, FAHA (1) · Michael S Avidan, MBBCh (1)